4//SEC Filing
Santos Esteban 4
Accession 0001127602-25-006284
CIK 0000318154other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 8:07 PM ET
Size
9.8 KB
Accession
0001127602-25-006284
Insider Transaction Report
Form 4
AMGEN INCAMGN
Santos Esteban
EVP, Operations
Transactions
- Exercise/Conversion
Nqso (Right to Buy)
2025-02-19−8,711→ 0 totalExercise: $156.35From: 2018-05-03Exp: 2026-05-03→ Common Stock (8,711 underlying) - Sale
Common Stock
2025-02-19$292.84/sh−8,711$2,550,903→ 71,546 total - Exercise/Conversion
Common Stock
2025-02-19$156.35/sh+8,711$1,361,965→ 80,257 total
Holdings
- 868.873(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]These shares were acquired in connection with the exercise of stock options expiring on May 3, 2026.
- [F2]The price reported is an average price. The prices ranged from $292.7523 to $293.00 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- [F3]These shares include 667 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- [F4]These shares are acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0001677950
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 8:07 PM ET
- Size
- 9.8 KB